Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
HealthEquity Analyst Ratings and Price Targets | NASDAQ:HQY | Benzinga
HealthEquity Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for HealthEquity Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Barrington Research
Deutsche Bank
Goldman Sachs
RBC Capital
B of A Securities
1calculated from analyst ratings
Analyst Ratings for HealthEquity
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/05/2025 | Buy Now | — | Barrington Research | Alexander Paris87% | $112 → $125 | Maintains | Outperform | Get Alert |
| 06/05/2025 | Buy Now | — | Deutsche Bank | George Hill60% | $98 → $115 | Maintains | Buy | Get Alert |
| 06/04/2025 | Buy Now | — | Goldman Sachs | David Roman40% | $94 → $104 | Maintains | Neutral | Get Alert |
| 06/04/2025 | Buy Now | — | RBC Capital | Daniel Perlin58% | $112 → $117 | Maintains | Outperform | Get Alert |
| 06/04/2025 | Buy Now | — | B of A Securities | Allen Lutz50% | $110 → $125 | Maintains | Buy | Get Alert |
| 06/04/2025 | Buy Now | — | JMP Securities | Constantine Davides40% | $110 → $117 | Maintains | Market Outperform | Get Alert |
| 05/22/2025 | Buy Now | — | RBC Capital | Daniel Perlin58% | → $112 | Assumes | → Outperform | Get Alert |
| 04/16/2025 | Buy Now | — | Keybanc | Scott Schoenhaus47% | $110 → $100 | Maintains | Overweight | Get Alert |
| 04/11/2025 | Buy Now | — | Barrington Research | Alexander Paris87% | $112 → $112 | Maintains | Outperform | Get Alert |
| 03/27/2025 | Buy Now | — | Goldman Sachs | David Roman40% | $107 → $94 | Maintains | Neutral | Get Alert |
| 03/25/2025 | Buy Now | — | Raymond James | C. Gregory Peters79% | $120 → $115 | Upgrade | Outperform → Strong Buy | Get Alert |
| 03/24/2025 | Buy Now | — | Keybanc | Scott Schoenhaus47% | $120 → $110 | Maintains | Overweight | Get Alert |
| 03/19/2025 | Buy Now | — | Barrington Research | Alexander Paris87% | $112 → $112 | Maintains | Outperform | Get Alert |
| 03/14/2025 | Buy Now | — | Barrington Research | Alexander Paris87% | $112 → $112 | Maintains | Outperform | Get Alert |
| 02/26/2025 | Buy Now | — | Wells Fargo | Stan Berenshteyn45% | $110 → $125 | Maintains | Overweight | Get Alert |
| 02/25/2025 | Buy Now | — | Raymond James | C. Gregory Peters79% | $105 → $120 | Maintains | Outperform | Get Alert |
| 12/10/2024 | Buy Now | — | JMP Securities | Constantine Davides40% | $105 → $107 | Maintains | Market Outperform | Get Alert |
| 12/10/2024 | Buy Now | — | RBC Capital | Sean Dodge46% | $100 → $105 | Maintains | Outperform | Get Alert |
| 12/04/2024 | Buy Now | — | Mizuho | Steven Valiquette63% | → $126 | Initiates | → Outperform | Get Alert |
| 12/02/2024 | Buy Now | — | Barrington Research | Alexander Paris87% | $105 → $120 | Maintains | Outperform | Get Alert |
| 11/15/2024 | Buy Now | — | Goldman Sachs | David Roman40% | → $108 | Initiates | → Neutral | Get Alert |
| 11/14/2024 | Buy Now | — | BTIG | David Larsen47% | $110 → $130 | Maintains | Buy | Get Alert |
| 11/13/2024 | Buy Now | — | B of A Securities | Allen Lutz50% | $100 → $120 | Maintains | Buy | Get Alert |
| 09/20/2024 | Buy Now | — | Barrington Research | Alexander Paris87% | $105 → $105 | Maintains | Outperform | Get Alert |
| 09/04/2024 | Buy Now | — | Barrington Research | Alexander Paris87% | $105 → $105 | Maintains | Outperform | Get Alert |
| 09/04/2024 | Buy Now | — | Deutsche Bank | George Hill60% | $102 → $103 | Maintains | Buy | Get Alert |
| 09/04/2024 | Buy Now | — | JMP Securities | Constantine Davides40% | $105 → $105 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 09/04/2024 | Buy Now | — | RBC Capital | Sean Dodge46% | $92 → $92 | Reiterates | Outperform → Outperform | Get Alert |
| 09/04/2024 | Buy Now | — | B of A Securities | Allen Lutz50% | $105 → $100 | Maintains | Buy | Get Alert |
| 08/30/2024 | Buy Now | — | Barrington Research | Alexander Paris87% | $105 → $105 | Maintains | Outperform | Get Alert |
| 07/03/2024 | Buy Now | — | B of A Securities | Allen Lutz50% | $105 → $105 | Maintains | Buy | Get Alert |
| 06/20/2024 | Buy Now | — | Wells Fargo | Stan Berenshteyn45% | $107 → $110 | Maintains | Overweight | Get Alert |
| 06/07/2024 | Buy Now | — | Raymond James | C. Gregory Peters79% | $100 → $105 | Maintains | Outperform | Get Alert |
| 06/05/2024 | Buy Now | — | Keybanc | Scott Schoenhaus47% | $95 → $100 | Maintains | Overweight | Get Alert |
| 06/04/2024 | Buy Now | — | Wells Fargo | Stan Berenshteyn45% | $105 → $107 | Maintains | Overweight | Get Alert |
| 06/04/2024 | Buy Now | — | Barrington Research | Alexander Paris87% | $100 → $105 | Maintains | Outperform | Get Alert |
| 06/04/2024 | Buy Now | — | RBC Capital | Sean Dodge46% | $92 → $92 | Reiterates | Outperform → Outperform | Get Alert |
| 06/04/2024 | Buy Now | — | B of A Securities | Allen Lutz50% | $97 → $105 | Maintains | Buy | Get Alert |
| 06/04/2024 | Buy Now | — | JMP Securities | Constantine Davides40% | $101 → $105 | Maintains | Market Outperform | Get Alert |
| 06/04/2024 | Buy Now | — | Baird | Mark Marcon72% | $98 → $104 | Maintains | Outperform | Get Alert |
| 04/04/2024 | Buy Now | — | JMP Securities | Constantine Davides40% | → $101 | Initiates | → Market Outperform | Get Alert |
| 04/02/2024 | Buy Now | — | JP Morgan | Anne Samuel52% | $86 → $108 | Maintains | Overweight | Get Alert |
| 03/22/2024 | Buy Now | — | Keybanc | Scott Schoenhaus47% | $85 → $95 | Maintains | Overweight | Get Alert |
| 03/22/2024 | Buy Now | — | Barrington Research | Alexander Paris87% | → $100 | Maintains | Outperform | Get Alert |
| 03/20/2024 | Buy Now | — | BTIG | David Larsen47% | $100 → $110 | Maintains | Buy | Get Alert |
| 03/20/2024 | Buy Now | — | RBC Capital | Sean Dodge46% | $90 → $92 | Maintains | Outperform | Get Alert |
| 03/20/2024 | Buy Now | — | B of A Securities | Allen Lutz50% | $93 → $97 | Maintains | Buy | Get Alert |
| 02/23/2024 | Buy Now | — | RBC Capital | Sean Dodge46% | $77 → $90 | Maintains | Outperform | Get Alert |
| 02/23/2024 | Buy Now | — | Barclays | — | $84 → $104 | Maintains | Overweight | Get Alert |
| 12/13/2023 | Buy Now | — | Raymond James | C. Gregory Peters79% | $90 → $95 | Maintains | Outperform | Get Alert |
| 12/06/2023 | Buy Now | — | Wells Fargo | Stan Berenshteyn45% | $89 → $93 | Maintains | Overweight | Get Alert |
| 12/04/2023 | Buy Now | — | Barrington Research | Alexander Paris87% | → $85 | Reiterates | Outperform → Outperform | Get Alert |
| 12/01/2023 | Buy Now | — | JP Morgan | Anne Samuel52% | $81 → $73 | Maintains | Overweight | Get Alert |
| 09/21/2023 | Buy Now | — | Baird | Mark Marcon72% | $79 → $87 | Upgrade | Neutral → Outperform | Get Alert |
| 09/07/2023 | Buy Now | — | Deutsche Bank | George Hill60% | $71 → $72 | Maintains | Buy | Get Alert |
| 09/06/2023 | Buy Now | — | Barrington Research | Alexander Paris87% | $80 → $85 | Reiterates | Outperform → Outperform | Get Alert |
| 09/06/2023 | Buy Now | — | RBC Capital | Sean Dodge46% | $75 → $77 | Maintains | Outperform | Get Alert |
| 06/07/2023 | Buy Now | — | Deutsche Bank | George Hill60% | $69 → $71 | Maintains | Buy | Get Alert |
| 06/06/2023 | Buy Now | — | RBC Capital | Sean Dodge46% | → $75 | Reiterates | → Outperform | Get Alert |
| 06/01/2023 | Buy Now | — | Barrington Research | Alexander Paris87% | → $80 | Reiterates | Outperform → Outperform | Get Alert |
| 03/24/2023 | Buy Now | — | Deutsche Bank | George Hill60% | $72 → $69 | Maintains | Buy | Get Alert |
| 03/22/2023 | Buy Now | — | Barrington Research | Alexander Paris87% | → $80 | Reiterates | → Outperform | Get Alert |
| 03/22/2023 | Buy Now | — | RBC Capital | Sean Dodge46% | → $75 | Reiterates | → Outperform | Get Alert |
| 02/03/2023 | Buy Now | — | Wells Fargo | Stan Berenshteyn45% | $101 → $89 | Maintains | Overweight | Get Alert |
| 01/24/2023 | Buy Now | — | Deutsche Bank | George Hill60% | $68 → $72 | Maintains | Buy | Get Alert |
| 12/12/2022 | Buy Now | — | Raymond James | C. Gregory Peters79% | $75 → $85 | Maintains | Outperform | Get Alert |
| 12/07/2022 | Buy Now | — | Guggenheim | Sandy Draper73% | $89 → $94 | Maintains | Buy | Get Alert |
| 12/07/2022 | Buy Now | — | Wells Fargo | Stan Berenshteyn45% | $104 → $101 | Maintains | Overweight | Get Alert |
| 12/05/2022 | Buy Now | — | RBC Capital | Sean Dodge46% | $70 → $75 | Maintains | Outperform | Get Alert |
| 10/25/2022 | Buy Now | — | Wells Fargo | Stan Berenshteyn45% | $100 → $104 | Maintains | Overweight | Get Alert |
| 10/21/2022 | Buy Now | — | Goldman Sachs | Cindy Motz21% | $64 → $77 | Upgrade | Sell → Neutral | Get Alert |
| 09/16/2022 | Buy Now | — | Keybanc | Scott Schoenhaus47% | → $85 | Initiates | → Overweight | Get Alert |
| 09/13/2022 | Buy Now | — | Wells Fargo | Stan Berenshteyn45% | $95 → $100 | Maintains | Overweight | Get Alert |
| 09/12/2022 | Buy Now | — | Raymond James | C. Gregory Peters79% | $70 → $75 | Maintains | Outperform | Get Alert |
| 09/08/2022 | Buy Now | — | Deutsche Bank | George Hill60% | $67 → $68 | Maintains | Buy | Get Alert |
| 09/07/2022 | Buy Now | — | Baird | Mark Marcon72% | $47 → $67 | Maintains | Neutral | Get Alert |
| 07/12/2022 | Buy Now | — | Goldman Sachs | Cindy Motz21% | → $59 | Initiates | → Sell | Get Alert |
| 06/08/2022 | Buy Now | — | Deutsche Bank | George Hill60% | $66 → $67 | Maintains | Buy | Get Alert |
| 06/07/2022 | Buy Now | — | SVB Leerink | Stephanie Davis41% | $67 → $76 | Maintains | Outperform | Get Alert |
FAQ
What is the target price for HealthEquity (HQY) stock?
The latest price target for HealthEquity (NASDAQ:HQY) was reported by Barrington Research on June 5, 2025. The analyst firm set a price target for $125.00 expecting HQY to rise to within 12 months (a possible 11.24% upside). 33 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for HealthEquity (HQY)?
The latest analyst rating for HealthEquity (NASDAQ:HQY) was provided by Barrington Research, and HealthEquity maintained their outperform rating.
When was the last upgrade for HealthEquity (HQY)?
The last upgrade for HealthEquity Inc happened on March 25, 2025 when Raymond James raised their price target to $115. Raymond James previously had an outperform for HealthEquity Inc.
When was the last downgrade for HealthEquity (HQY)?
There is no last downgrade for HealthEquity.
When is the next analyst rating going to be posted or updated for HealthEquity (HQY)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of HealthEquity, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for HealthEquity was filed on June 5, 2025 so you should expect the next rating to be made available sometime around June 5, 2026.
Is the Analyst Rating HealthEquity (HQY) correct?
While ratings are subjective and will change, the latest HealthEquity (HQY) rating was a maintained with a price target of $112.00 to $125.00. The current price HealthEquity (HQY) is trading at is $112.37, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
